Bh i dont whether we supplied them or they never made it due to that qc problem with part/all of the batch.
So worst case is we lost 20,000 membranes at lets say 50 cents cost price each.
The otehr thing to remember is that the chinese are charging people directly from the oraline test.
No pathology follow up its just bang positive and your gone.
So my opinion is maybe the mps or siyi had a squiz at our qc controls or maybe a couple of the membranes in the 20,000 batch failed and rather than risk it they shelved the lot.
SBN and the MPS then went down course of sbn has to guarantee 100% quality (due to no follow confirmation being taken so qc reports to be supplied) and from mps side they will reduce the number in the trial so timeframes are kept.
The above is only what i think may have happened after reading the update about 20,000 times.
As i keep saying in the end if it improves quality and hasnt pissed the mps off to much and has kept them happy the the loss of a bit of revenue is small price to pay apart from the embarressment.
Maze,
Honestly i think the import licence (if we get it) will do absolutely stuff all to the sp maybe back to 1 cent.
I think we will only see growth when deals are ann with dollars attached wherever they are from.
And even then i hve absolutely no idea what it might do in this market. It could go through the roof or stay absolutley where it is.
Have a good one
- Forums
- ASX - By Stock
- SBN
- 2 & 2
2 & 2, page-17
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SBN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online